Anxiety disorders are among the most common psychiatric disorders, with a lifetime prevalence of approximately 25% in adults \[[@CR1]\] and 4--9% in children \[[@CR2], [@CR3]\]. Moreover, many adult anxiety disorders have their onset in childhood or adolescence and may have a chronic course \[e.g., [@CR4], [@CR5]\]. They are also highly co-morbid with each other and other psychiatric disorders, especially with mood disorders \[e.g., [@CR6]\] and are associated with high levels of occupational and social impairment \[e.g., [@CR7]\].

The Diagnostic and Statistical Manual of Psychiatric Disorders (DSM-IV-TR) \[[@CR8]\] specifies the following types of anxiety disorders in children and adults: separation anxiety, panic disorder (PD), agoraphobia, specific phobia, social phobia, generalized anxiety disorder (GAD), obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and acute stress disorder (Table [1](#Tab1){ref-type="table"}). Table 1Diagnostic features of the *DSM-IV-TR* anxiety disordersDisorderKey diagnostic featuresSeparation anxietyExcessive anxiety associated with separation from home or caregiversPanic disorderPanic attacks and persistent concern about the future recurrence of attacks as well as worry about the consequences of the panicSpecific phobiaExcessive fear of specific objects or situations, subsequent avoidance of those, and/or distress associated with exposure to these objects or situationsSocial phobiaExcessive fear of social and performance situations and subsequent avoidance of and/or distress associated with exposure to the situationGeneralized anxiety disorderExcessive worry or anxiety across a number of situations and events, which is hard to controlObsessive-compulsive disorderPersistent intrusive thoughts that may not make sense and/or repetitive driven behaviors that the individual performs in response to obsession or in accordance with specific rulesPosttraumatic stress disorderPersistent re-experiencing of a traumatic event through intrusive recollections, dreams, or flashbacksAcute stress disorderShort-term re-experiencing, dissociation, distress, and avoidance of stimuli associated with exposure to extreme stress

Given their high prevalence and the accompanying impairment, the etiology of anxiety disorders is of major interest and importance. It has been investigated through a number of genetic approaches, including family studies, which provide information about the familial aggregation of the disorder \[[@CR9]\]; twin studies, which investigate heritability of the disorder by comparing the concordance rate for a specific condition in pairs of monozygotic (MZ) and dizygotic (DZ) twins \[[@CR9]\]; and association and linkage studies, which seek to identify specific genes or chromosomal regions related to anxiety disorders \[[@CR10]\].

Family studies of anxiety disorders \[[@CR11]--[@CR13]\] have demonstrated familiality of specific anxiety disorders. Familial aggregation of anxiety disorders in general has been demonstrated as well. For example, Merikangas and colleagues \[[@CR14]--[@CR16]\] found that the risk of developing an anxiety disorder in children aged 7--17 years was three times as high if a parent had an anxiety disorder as if a parent had a substance abuse disorder or neither parent had a psychiatric diagnosis. Turner, Bidel, and Costello \[[@CR17]\] found that children of parents with anxiety disorders were seven times more likely to develop an anxiety disorder than children of control parents without a psychiatric diagnosis.

Several twin studies of specific anxiety disorders have been conducted \[[@CR18]--[@CR21]\]. In most studies the concordance rates were higher for MZ twins than for DZ twins. Hettema et al. \[[@CR22]\], in a meta-analysis of twin studies of anxiety disorders, estimated 30--40% heritability for anxiety disorders, depending on the disorder.

Multiple molecular genetic studies of anxiety disorders have been conducted as well, including linkage and association studies. Although several candidate chromosomal regions, genes, and polymorphisms have been linked to anxiety disorders \[reviewed in [@CR10]\], many of the initial findings are conflicting, and no specific genes have been identified thus far. This is not surprising; although anxiety disorders aggregate in families, their mode of inheritance does not follow a clear Mendelian pattern (i.e., dominant, recessive, or X-linked). Instead, these are complex disorders that appear to be caused by an interaction among a variety of genes as well as environmental factors \[[@CR23]\]. Additionally, because the pathophysiology of anxiety disorders remains unclear, choosing candidate genes for association studies is not easy.

A number of chromosomal and genetic disorders caused by deletions, trisomies, or translocations are associated with specific behavioral characteristics, referred to as behavioral phenotypes \[[@CR24]\]. Although these behavioral characteristics may include psychiatric features, the complete profiles of psychiatric features and their risk factors in these disorders are unknown. Examination of genetic neurodevelopmental disorders associated with high prevalence rates of a particular psychiatric disorder may provide a complementary approach in the search for susceptibility genes for complex disorders \[[@CR25]\]. Association studies can be conducted using the genetic markers on the locus or the genes implicated in the chromosomal abnormality. Also, hypotheses may be made about the interaction of the chromosomal region involved in the abnormality and genes that have already been implicated in these disorders in previous studies.

Karayiorgou and Gogos \[[@CR26]\] state that to determine reliably a causal relation between a chromosomal abnormality and a disease, one or preferably both of the following criteria must be demonstrated: 1) increased frequency of the disease in a population with the chromosomal abnormality and 2) increased frequency of the chromosomal abnormality in the population with the disease. Studies of complex disorders such as schizophrenia and Alzheimer disorder \[e.g., [@CR25], [@CR27], [@CR28]\] have demonstrated the success of this approach. For example, findings of elevated prevalence of schizophrenia in individuals with 22q11 deletion syndrome have prompted genetic linkage and association studies of schizophrenia on chromosome 22q, which have led to finding a potential schizophrenia susceptibility locus on chromosome 22q \[reviewed in [@CR25]\]. Similar strategies can be applied to genetic studies of anxiety disorders.

Williams syndrome (WS) is a neurodevelopmental disorder caused by a microdeletion of \~25 genes on chromosome 7q11.23 \[[@CR29], [@CR30]\]. It is associated with mild to moderate intellectual disability or learning difficulties, a characteristic facies, heart disease (especially supravalvar aortic stenosis), hypercalcemia, and failure to thrive in infancy \[[@CR31]\]. The cognitive phenotype for WS includes relative strengths in verbal short-term memory and language and extreme weakness in visuospatial construction, including writing, drawing, and pattern construction \[e.g., [@CR32]\]. A number of studies have considered the behavioral and emotional characteristics of individuals with WS \[[@CR33]--[@CR41]\], identifying such characteristics as anxiety, restlessness, and mood swings. However, most of these reports did not assess for DSM-IV diagnoses of anxiety disorders.

Leyfer, Woodruff-Borden, Klein-Tasman, Fricke, and Mervis \[[@CR42]\] examined the prevalence of psychiatric disorders in 119 children with WS aged 4--16 years, using the Anxiety Disorders Interview Schedule, Parent version (ADIS-P) \[[@CR43]\], a semi-structured diagnostic interview, which allows for making differential diagnoses among the *DSM-IV* anxiety and mood disorders. The results demonstrated prevalence rates of 54% for specific phobia, 12% for generalized anxiety disorder (GAD), 7% for separation anxiety disorder, 3% for obsessive-compulsive disorder (OCD), 2% for social phobia, 1% for post traumatic stress disorder (PTSD), and 1% for panic disorder.

In summary, the preliminary evidence suggests that anxiety disorders are found at higher prevalence in individuals with WS, and hence WS may be used to search for genes implicated in anxiety disorders. However, the causes of anxiety in individuals with WS are unclear. Systematic studies of anxiety disorders in individuals with WS and their first-degree relatives will shed light on the possible relations between family history of anxiety and anxiety disorders in individuals with WS and open the door for further studies of pathophysiology of anxiety. The purpose of this paper is to provide the first such study.

No studies have examined the prevalence of anxiety disorders in family members of individuals with WS. Studies of anxiety in the first degree relatives of children with other forms of developmental disability (DD) \[[@CR44]--[@CR48]\] do not clearly demonstrate whether parents of children with DD have elevated anxiety in comparison to the general population. However, it is possible that anxiety levels among parents of children with DD may vary depending on the child's behaviors, level of functioning, and other such variables. Such relations have been reported for parenting stress. For example, Weiss, Sullivan, and Diamond \[[@CR49]\] demonstrated that lower adaptive functioning scores in children with DD predict higher levels of parental stress. Emerson \[[@CR50]\] found that the following factors related to having a child with DD contributed to the prevalence of mental health problems in the mothers: if the child with DD is a male, poverty, and the parent's perception of the social impact of the child's difficulties.

Fidler, Hodapp, and Dykens \[[@CR51]\] examined which child variables may affect the levels of stress in families of 20 children with WS, Down syndrome (DS), and Smith--Magenis syndrome. Results indicated that for the parents of the children with WS, younger age of the child and maladaptive behavior as measured by the CBCL Total Problems T score \[[@CR52]\] accounted for 59% of the variance in family stress. These findings suggest that child variables such as adaptive functioning and behavioral problems may be predictive of anxiety in parents of children with WS. Demographic factors such as employment, child age, and child gender may also predict anxiety in parents of children with WS.

A few studies of siblings of children with other forms of DD have been conducted, with contradictory results. McHale and Gamble \[[@CR53]\] reported a significantly higher anxiety score for siblings of children with intellectual disability (ID) than for the controls on the Revised Children's Manifest Anxiety Scale (RCMAS) \[[@CR54]\]. In contrast, using the same measure, Coleby \[[@CR55]\] did not find a difference in the anxiety score between the two groups of siblings.

In summary, very few studies have investigated anxiety in parents and siblings of children with DD. The purpose of the current study was to determine the prevalence of anxiety disorders in children with WS, their sibling closest in age, and their mothers and to examine the predictors of anxiety in these groups, to help determine if hemideletion of one or more genes in the WS region is likely to contribute to anxiety disorders.

Method {#Sec1}
======

Participants {#Sec2}
------------

The participants were recruited through a study of language and cognitive development in children with WS conducted by Drs. Carolyn Mervis and Colleen Morris at the University of Louisville and the University of Nevada School of Medicine. The University of Louisville site primarily focuses on cognitive and language development, while the University of Nevada site focuses on genetic and medical aspects of WS. Participants eligible for the study included mothers who had biological children between the ages of 4--16 years with genetically-confirmed WS. The majority of the families also had another child in the same age range (half-siblings were included if they had the same mother). Exclusionary criteria for the participants were: 1) the presence of another genetic or developmental disorder in the child with WS (*n* = 11; in all cases autism or pervasive developmental disorder, not otherwise specified), 2) the presence of organic brain damage in the child with WS (*n* = 2), and 3) the presence of a developmental disorder or organic brain damage in the mother or the sibling of the child with WS (*n* = 1). The characteristics of the sample are presented in Table [2](#Tab2){ref-type="table"}. Table 2Demographic information Children with WSSiblingsMothers*N*13284132Age M (SD), Range8.5 (3.3), 4.0--16.99.7 (3.1), 4.2--16.638.7 (5.9), 22.7--58.2Sex *N* (%)Males63 (47.7%)44 (52.4%)Females60 (52.3%)40 (47.6%)DAS GCA M (SD), Range60.2 (13.6), \<25--94SIB-R Broad Ind.M (SD), Range55.9 (14.3), 15--95Marital status *N* (%)Married113 (86%)Divorced15 (11%)Single4 (3%)Income *N* (%)\<\$30,00016 (12%)\$21--60,00026 (20%)\$61--90,00045 (34%)\>\$91,00045 (34%)Employment *N* (%)^1^Employed*N* = 72 (54.5%)Unemployed*N* = 40 (45.5%)^1^ No difference found in income between families with employed and unemployed mothers (*p* = .772).Note. DAS GCA = Differential Ability Scales General Conceptual Ability score; M(SD) = Mean (standard deviation); SIB-R Broad Ind = Scales of Independent behavior-Revised Broad independence score.

Measures {#Sec3}
--------

**Anxiety Disorders Interview Schedule-IV (ADIS-IV) \[[@CR56]\]** Maternal diagnostic status was obtained with the ADIS-IV, a semi-structured diagnostic interview that allows for differential diagnoses of DSM-IV anxiety and related disorders in adults. The ADIS-IV provides information both about specific anxiety disorder diagnoses and their severity \[rated on a scale from 0 (no anxiety) to 8 (very severe anxiety)\].Although no psychometric data are available for the ADIS-IV, the ADIS-IV: Lifetime Version (ADIS-IV-L) has been reported to have good to excellent reliability (kappas .58--.81) \[[@CR57]\]. Adequate test--retest reliability has also been reported for the predecessor of the ADIS-IV, the ADIS-Revised \[[@CR58]\], with kappas of.43 to.82.

**Anxiety Disorders Interview Schedule, Parent version (ADIS-P) \[[@CR42]\]** The ADIS-P is a semi-structured interview designed to diagnose anxiety disorders in children and adolescents (through age 16 years). It is based on DSM-IV criteria and is used both to determine the diagnosis and its severity. The ADIS-P allows for differential diagnoses among all the DSM-IV anxiety and related disorders and provides data regarding symptomatology, etiology, and the course of the disorder \[[@CR59]\]. The ADIS-P also provides information about the severity of any diagnoses using the same scale as the ADIS-IV. Silverman, Saavedra, and Pina \[[@CR60]\] found excellent reliability for separation anxiety disorder, social phobia, specific phobia, and GAD as well as excellent test--retest reliability for the interview.Semistructured diagnostic interviews have several advantages in comparison to questionnaires and rating scales. First, they provide specific diagnoses based on a diagnostic system such as the *DSM*. Thus, symptoms and behaviors are grouped into diagnostically meaningful clusters and onset, impairment, and other variables are taken into account. Second, the interviewer can ask additional questions or vary the wording of questions in order to be certain that the informant understands the question. Third, the interviewer can solicit examples of the behavior in question, ensuring the accuracy of the data.The applicability of DSM-IV criteria to populations with DD has been widely discussed in the literature. Cooper, Melville, and Einfeld \[[@CR61]\] and Reiss, Levitan, and Szyszko \[[@CR62]\] argue that reported prevalence rates of psychopathology may be an underestimate in populations with DD. Sovner and Hurley \[[@CR63]--[@CR66]\] suggested that although they may be less likely to be diagnosed, adults with DD have psychiatric disturbances that are conceptually the same as DSM disorders. Brown, Aman, and LeCavalier \[[@CR67]\] argued that DSM-IV criteria are applicable to children and adolescents with mild or moderate intellectual disability. The IQs of 5.3% of the children with WS in the present study were in the range of severe intellectual disability, suggesting that the results may be a slight underestimate of the actual rates of anxiety disorders.

**Differential Ability Scales (DAS) \[[@CR68], [@CR69]\]** The DAS provides an assessment of general intellectual functioning. This measure was designed to provide specific information about an individual\'s strengths and weaknesses across a wide range of intellectual activities. The General Conceptual Ability (GCA; similar to IQ) is based on performance on the core subtests and has a mean of 100 and a standard deviation of 15.There are two levels of the DAS: Preschool and School Age. Following the test author's recommendation for children who are expected to have below average intelligence, the Preschool Level was administered to all children who were 6 years 11 months or younger. The School Age Level was administered to the remaining children unless they were very low functioning; these children completed the Preschool Level. If necessary, the GCA was calculated using the extended norms, which are available for the Preschool Level through age 13 years 11 months and for the School Age Level through age 17 years 11 months.

**Scales of Independent Behavior-Revised (SIB-R) \[[@CR70]\]** The SIB-R provides an assessment of adaptive behavior. The parent interview form of the instrument was administered. It consists of 259 items; each item is scored on a 4-point Likert scale. The items are divided into four clusters: Motor Skills, Social Interaction and Communication, Personal Living Skills, and Community Living Skills. The Broad Independence standard score is based on parental responses to items in all four clusters. This standard score has a mean of 100 and a standard deviation of 15. Additionally, the SIB-R assesses three domains of maladaptive behavior: Internalized, Asocial, and Externalized. The norms for the SIB-R extend from age 3 months to 90 years.

**Child Behavior Checklist (CBCL) \[[@CR71], [@CR72]\]** The CBCL is a Likert scale that provides an assessment of behavioral and emotional problems of children from parents and/or other caregivers. There are two versions of this instrument: one for children aged 1 1/2--5 years and another for children aged 6--18 years. The Total Problems T score was used as a measure of behavioral problems in this study.

Training/reliability of student clinical interviewers {#Sec4}
-----------------------------------------------------

All interviewers who administered the ADIS-IV and ADIS-P had successfully completed reliability training for the interview. Training for the ADIS consisted of the following components: reviewing the interview, observing videotaped or live administrations of the interview, and assigning diagnoses and severity ratings for each interview. Interviewers were required to obtain three consecutive matches on diagnosis and its severity. Upon completion of this process, the interviewer administered a practice ADIS. This interview was videotaped and was rated by a licensed clinical psychologist. If the interviewer and the clinical psychologist diagnoses matched on principal and additional diagnoses as well as severity, the interviewer was permitted to administer the ADIS for the study. All interview protocols were reviewed with a licensed clinical psychologist. Disagreements were resolved by discussion.

Results {#Sec5}
=======

Prevalence rates of anxiety disorders in children with WS {#Sec6}
---------------------------------------------------------

Prevalence rates for each type of anxiety disorder in children with WS are shown in Table [3](#Tab3){ref-type="table"}. Overall, 62.1% of the children received a diagnosis of at least one anxiety disorder. The most prevalent anxiety disorder was specific phobia, found in 56.1% of the children. These prevalence rates were compared to those in the general population of children using a *z*-test, with the significance level set at.05. For this comparison, the findings of the Child and Adolescent Mental Disorders Study \[[@CR3]\], the largest epidemiological study of psychiatric disorders in children in the USA using a reliable and valid structured diagnostic interview, the Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3) \[[@CR3]\], were used (Table [3](#Tab3){ref-type="table"}). We also compared these data to the prevalence rates of anxiety disorders in the largest epidemiological study of psychiatric disorders in children with DD \[[@CR73]\], using the DISC-IV \[[@CR74]\]. The children with WS had a significantly higher prevalence of specific phobia, GAD, and separation anxiety than did children either in the general population or an epidemiological sample of children with DD. Table 3Prevalence of anxiety disorders in children with WS (*N* = 132), children in the general population, and children in the DD populationType of anxiety disorderWSPopulation prevalence^a^DD population prevalence^b^*N*%%%Separation anxiety disorder86.12.3\*1.9\*Social phobia32.34.51.9GAD107.63.1\*0\*\*OCD21.5--^c^1.5Specific phobia7456.11.3\*\*6.8\*\*PTSD21.5--^c^--^c^\**p* \< .01; \*\**p* \< .001^a^Prevalence established using the Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3), Parent version^b^Prevalence established using the DISC-IV, Parent version^c^Prevalence not reported.

The prevalence rates of types of anxiety disorders were also compared between children with WS who had a sibling in the 4--16 year age range and those who did not. No significant difference was found in the prevalence of either anxiety disorders in general or specific anxiety disorders between the two groups.

Prevalence rates of anxiety disorders in mothers of children with WS {#Sec7}
--------------------------------------------------------------------

Lifetime prevalence of each type of anxiety disorder for the mothers participating in the study is reported in Table [4](#Tab4){ref-type="table"}. The prevalence for each anxiety disorder was then compared to the prevalence in the general population of women in the same age range, using a *z* test, with a significance level of *p* \< .05. For population prevalence, the findings of the National Comorbidity Study Replication (NCS-R) were used \[[@CR75]; Table [4](#Tab4){ref-type="table"}\], adjusted to include the age range of the participants in the present study. The prevalence of GAD in the mothers of children with WS was significantly higher than in the general population of women. Table 4Prevalence of anxiety disorders in mothers of children with WS (*N* = 132)Type of anxiety disorder*N*%Population Prevalence (%)^a^Social phobia1511.415.7GAD3123.58.1\*\*OCD32.31.6Specific phobia2720.517.9PTSD53.810.9\*Panic disorder43.07.7\**p* \< .01; \*\**p* \< .001^a^Prevalence assessed using the Composite International Diagnostic Interview

To control for the influence of having a child with DD, the prevalence of GAD in the mothers *prior* to the birth of their child with WS was examined, taking into consideration the date of onset of GAD as reported by the mothers. This prevalence (6.4%) was similar to that for the general population (*z* = 0.2, *p* = .827).

Prevalence rates of anxiety disorders in siblings of children with WS {#Sec8}
---------------------------------------------------------------------

Prevalence rates of each type of anxiety disorder in siblings of children with WS (*N* = 84) are reported in Table [5](#Tab5){ref-type="table"}. Overall, 25% of the siblings had a diagnosis of at least one anxiety disorder. The prevalence of each anxiety disorder and of any anxiety disorder was compared to the prevalence in the general population of children with typical development (TD), using a *z* test, with a significance level of *p* \< .05. For population prevalence, the findings of the Child and Adolescent Mental Disorders Study \[[@CR3]; Table [3](#Tab3){ref-type="table"}\] were used. The siblings of children with WS had a significantly higher prevalence of specific phobia (*p* \< .001) than Shaffer et al. reported for children in the general population. Table 5Prevalence of anxiety disorders in children with WS and their siblingsType of anxiety disorderTD (*N* = 84)WS (*N* = 84)*N*%*N*%Any anxiety disorder2125.05160.7\*Separation anxiety33.633.6Social phobia67.122.4GAD56.0910.7OCD0022.4Specific phobia1416.74452.4\*\**p* \< .001

The prevalence rates of anxiety disorders overall in children with WS were then compared to the prevalence in their TD siblings, using the McNemar test, a statistic used to test matched-pair data \[[@CR76]\], with a significance level of *p* \< .05. To control for environmental and genetic influences, only the subset of children with WS who had a sibling participating in the study (*N* = 84) was used for this analysis. (No difference was found in the prevalence of anxiety disorders between children with WS with and without siblings in the 4--16 year age range.) The children with WS had a significantly higher prevalence of anxiety disorders overall than their siblings (*p* \< .001). The children with WS also had a significantly higher prevalence of specific phobia than their siblings (*p* \< .001). Comparisons for the remaining categories of anxiety disorders were not performed because of the low expected frequencies for some of the cells. Note, however, that the prevalence of GAD for the children with WS was almost double that of their siblings and that the prevalence of social phobia for the children with WS was one-third that of their siblings.

Predictors of anxiety in children with WS {#Sec9}
-----------------------------------------

A logistic regression was conducted to determine the factors related to the presence of anxiety disorders in children with WS. The child's DAS GCA score, the age of the child with WS, the sex of the child with WS, and severity of maternal anxiety (M = 1.6, SD = 2.2) were entered as covariates (Table [6](#Tab6){ref-type="table"}). The overall regression equation was significant, *χ*^2^ (4) = 22.06, *p* \< .001. The model accounted for 22.0% of the variance in the anxiety in the child with WS. The odds of a child with WS having an anxiety disorder increased with the severity of maternal anxiety. Table 6Logistic regression analysis summary for predictors of anxiety in children with WSModel*Β*SEOdds ratioAge.03.061.03Sex−.58.42.56DAS GCA−.02.02.98Severity of maternal anxiety.42.121.52\*\**p* \< .01

Predictors of anxiety in mothers of children with WS {#Sec10}
----------------------------------------------------

A logistic regression analysis was conducted to determine the extent to which the age, IQ, overall behavioral problems of the child with WS, and maternal employment status predicted the presence of maternal anxiety. For this analysis, the mothers who reported the onset of their anxiety as occurring before having a child with WS were excluded (*n* = 14). The age of the child with WS, the child's DAS GCA, the child's CBCL Total Problems T score, and maternal employment status were entered as covariates (Table [7](#Tab7){ref-type="table"}). The overall regression equation was significant, *χ*^2^ (4) = 10.1, *p* = .039, the model accounting for 12.0% of the variance of the presence of anxiety in mothers. The odds of the mother having an anxiety disorder increased significantly as the child's GCA decreased and marginally if the mother was employed outside of home. Table 7Logistic regression analysis summary for predictors of anxiety in mothers of children with WSModel*Β*SEOdds ratioAge of the child with WS.06.061.06DAS GCA−.03.02.96\*Total problem behavior.02.031.02Maternal employment−.77.42.46\*\*\**p* \< .05; \*\**p* = .07

Predictors of anxiety in siblings of children with WS {#Sec11}
-----------------------------------------------------

A logistic regression was conducted to test whether maternal anxiety, sibling age, and sibling sex predicted anxiety in the siblings. The overall regression equation was not significant, *χ*^2^ (3) = 3.6, *p* = .312, the model predicting only 7% of the variance. The prevalence rates of anxiety disorders overall in the siblings were then compared to the prevalence in their mothers, using the McNemar test, a statistic used to test matched-pair data \[[@CR76]\], with a significance level of *p* \< .05. For this analysis, we excluded the mothers who had the onset of anxiety after having a child with WS. No significant results were obtained (*p* = .332). Spearman's rho was computed to investigate whether sibling anxiety correlated with the CA (−.14), severity of anxiety (.20), DAS GCA (−.11), SIB-R Broad Independence (−.05), or CBCL Total Problems T score (.10) of children with WS. None of these correlations was significant.

Discussion {#Sec12}
==========

The present study investigated the prevalence of anxiety disorders in children with WS, their mothers, and their siblings, using a DSM-IV-based semi-structured diagnostic interview with good psychometric properties. In addition, this study investigated potential predictors of anxiety in children with WS, their mothers, and their siblings. The results are discussed in the order of groups in the study: children with WS, their mothers, and their siblings. The final section focuses on the implications of these findings for the genetics of anxiety disorders.

Children with WS {#Sec13}
----------------

The results of this study demonstrate that children with WS have elevated rates of anxiety disorders in comparison to children in the general population. When examined by type, children with WS have a significantly higher prevalence of specific phobia, GAD, and separation anxiety than children in the general population. The same pattern was found when the prevalence of anxiety disorders in children with WS was compared to that in an epidemiological sample of children with DD of mixed etiology \[[@CR73]\].

These rates are also much higher than those previously reported for individuals with DD of other etiologies. Myers and Pueschel \[[@CR77]\] reported phobias in only 1.5% of their sample of children and adolescents with Down syndrome. Backes et al. \[[@CR78]\] reported separation anxiety in 10% and OCD in 2% of children with Fragile X syndrome. In a study of prevalence of psychiatric disorders in 264 children with DD of mixed etiology, Emerson \[[@CR79]\] reported 1.9% prevalence of specific phobia and 2.7% prevalence of separation anxiety. In the present study, the children with WS also had a significantly higher prevalence of specific phobia than their siblings. No comparisons with siblings were made for other anxiety disorders because of the low frequency in both groups.

The presence of maternal anxiety may further increase the rate of anxiety disorders in children with WS. Studies of children with TD have already demonstrated that the risk for anxiety disorders is higher for children of anxious parents than children of parents without anxiety \[[@CR13]--[@CR16]\]. However, children with WS have a much higher prevalence rate of anxiety disorder (62.1%) than that reported for children of anxious parents (33%) \[[@CR80]\].

These findings overall demonstrate an elevated rate of anxiety disorders in children with WS, which per Karayiorgou and Gogos \[[@CR25]\] is one of the two criteria demonstrating a causal relation between a chromosomal abnormality and a disease, in this case 7q11.23 deletion and anxiety. It appears that the deletion increases the risk for developing an anxiety disorder in children with WS. The logistic regression results indicate that familial aggregation of anxiety may also contribute to the risk of developing an anxiety disorder in children with WS. This finding is consistent with results of family studies of anxiety disorders. An important focus for future research is to further investigate the separate and combined contributions of particular deleted gene(s) and history of maternal anxiety to anxiety in children with WS.

Mothers of children with WS {#Sec14}
---------------------------

In this study, mothers of children with WS reported a significantly higher lifetime prevalence of GAD than women in the general population. Because no large studies have examined the prevalence of anxiety disorders in mothers of children with DD, no statistical comparisons were conducted with such populations. However, the mothers of children with WS also had a notably higher prevalence of anxiety disorders than mothers of children with Down syndrome or autism in previous studies, which have reported rates similar to or lower than those in the general population \[[@CR47]--[@CR48]\].

When the age of onset of GAD in the mothers was taken into account, it appeared that the prevalence rate for GAD for mothers of children with WS prior to the birth of the child with WS (as reported by the mothers in retrospect) was comparable to that for women in the general population, suggesting that maternal GAD may be at least in part related to the stress of raising a child with WS. One question is why mothers of children with WS have increased prevalence of GAD rather than of other types of anxiety disorders. It is possible that the diagnostic criteria for GAD (excessive worry or anxiety across a number of situations and events, which is difficult to control) \[[@CR8]\] encompass the stressors directly associated with raising a child with WS, such as health, school, and behavior as well as stressors likely due to having a child with WS, but involving other family members, including spousal relations and parental relations with TD children. This finding is consistent with previous findings on the onset of GAD, demonstrating that later-onset GAD is associated with the emergence of life stressors \[e.g., [@CR81]--[@CR83]\]. A potential limitation of this finding is that the onset of maternal GAD is based on a retrospective report by the mothers, and it is possible that the report is inaccurate and the mothers of children with WS have a higher prevalence of GAD than the women in the general population even prior to having the child with WS.

In the present study, child IQ significantly affected the odds of a mother having an anxiety disorder, suggesting that higher IQ was associated with decreased odds of the mother having an anxiety disorder. Additionally, mothers who were not employed outside of the home also had a marginally increased likelihood of having an anxiety disorder relative to mothers who were employed outside of the home. This difference was not due to lower family income; family income in families where the mothers were not employed was very similar to family income where the mothers were employed. This finding is consistent with that of Wittchen et al. \[[@CR84]\], who found that in the National Comorbidity Survey being unemployed and being a homemaker were significantly correlated with the presence of GAD.

Overall, these findings suggest that the mothers of children with WS are at increased risk for developing an anxiety disorder later in life, which may be due to the environmental stress of raising a child with WS. It is possible that some of the mothers of children with WS may have a predisposition to developing an anxiety disorder which then becomes apparent in the presence of an environmental stressor. This is consistent with evidence from genetic studies. For example, in a study of 1,033 blindly assessed female--female twin pairs, Kendler et al. \[[@CR85]\] estimated 30% heritability for GAD and postulated that the remainder of the variance may be accounted for by environmental factors.

Several steps may be taken to explore this issue further. First, studies are needed to compare the prevalence rates of anxiety disorders in mothers of children with WS with those of mothers of children with other types of DD. Second, larger studies examining potential environmental stressors in these mothers may also help clarify the relation between these stressors and the onset of anxiety. Examination of the interaction of the potential anxiety candidate genes and environmental influences and its effect on anxiety in this population will help explain the prevalence findings in the mothers and advance our knowledge of the etiology of anxiety disorders.

Siblings of children with WS {#Sec15}
----------------------------

The siblings of children with WS had the same prevalence of anxiety disorders as children in the general population as measured by Shaffer et al. \[[@CR3]\], with the exception of specific phobia. However, while the prevalence of specific phobia in siblings of children with WS was higher than that reported by Shaffer et al. \[[@CR3]\], it was similar to the rates reported in other studies of specific phobia in children with TD \[[@CR86], [@CR87]\]. Lichtenstein and Annas \[[@CR86]\] examined the prevalence of specific phobia in 1106 pairs of 8--9-year-old twins (both DZ and MZ), using a DSM-IV based questionnaire, and reported a rate of 8.6%. Muris and Merckelbach \[[@CR87]\] administered the specific phobia sections of the DISC-2.3 \[[@CR3]\] to parents of 160 children aged 4--12 years and found a 17.6% prevalence of specific phobia. These findings suggest that the prevalence rate of specific phobia in the children in general population reported in Shaffer et al. \[[@CR3]\] may be an underestimate. If so, the siblings of children with WS would not evidence increased prevalence of any anxiety disorder relative to children in the general population.

Neither history of maternal anxiety nor any factors related to the sibling with WS, such as IQ, behavior problems, or severity of anxiety disorder in the child with WS, predicted or correlated with the presence of anxiety disorder in the siblings. These results may be due to the small number of siblings who had an anxiety disorder. A study with a larger number of siblings of children with WS who have anxiety may be successful at identifying predictors of anxiety in the siblings. Additionally, comparison groups of siblings of children with DD and siblings of children from families in which all children are typically developing may help further clarify these findings.

Implications for genetic research on anxiety disorders {#Sec16}
------------------------------------------------------

Research on complex disorders has demonstrated that examination of neurodevelopmental disorders of known genetic cause that are associated with high prevalence rates of a particular psychiatric disorder may be successful in identifying susceptibility genes for these disorders. Thus far this approach has not been applied to anxiety disorders. These and previous findings by Leyfer et al. \[[@CR42]\] indicate that there may be a causal relation between anxiety and deletion of chromosome 7q11.23 \[[@CR26]\]. It is thus possible that there is a susceptibility locus for anxiety on 7q11.23. This possibility can be further tested by means of genetic linkage and association studies. From this point on several strategies may be implemented to identify how 7q11.23 deletion may contribute to anxiety. For example, hemideletion of one or more genes in the WS region may cause increased anxiety. To test this possibility, association studies may be conducted on genes contained in the deleted region, using samples of TD individuals with and without an anxiety disorder.

It is also possible that the increased prevalence of anxiety in WS is due to the impact of the deletion of one or more genes in the deleted region on genes outside that region that are involved in anxiety. To test this possibility, association studies on anxiety can be conducted with individuals with WS targeting genes that have already been implicated in anxiety. Although the findings of association studies of anxiety disorders are conflicting thus far, several genes may be of potential interest. COMT, an enzyme responsible for the metabolism of noradrenaline and dopamine, encoded by a gene located on 22q11 \[[@CR9]\] has been implicated in panic disorder \[[@CR87]\] and OCD \[[@CR88], [@CR89]\]. Another gene that may be of potential interest is a variant of the serotonin transporter (SERT) gene, implicated in personality traits related to anxiety \[[@CR90], [@CR91]\]. These genes can also be investigated in the mothers of children with WS.

When conducting association studies, several problems may arise. First, the selection of the control group will affect the results tremendously, because the differences between the two groups may not be related to genetics. For example, differences in allele frequencies may vary among different subgroups. To minimize such problems, Arnold et al. \[[@CR10]\] suggest using family-based association methods. The mothers and siblings of children with WS can serve as the comparison group in future association studies. Future studies will need to focus on examining the prevalence of anxiety disorders in fathers of children with WS to determine the impact of paternal anxiety on anxiety in children with WS. It would also be useful to conduct large scale comparison studies of anxiety disorders and their predictors in children with WS, their siblings, and their parents and children with other types of DD, their siblings, and their parents.

In conclusion, given the increased prevalence of anxiety disorders in children with WS, genetic studies examining possible links between particular genes deleted in WS and anxiety are warranted. It would also be worthwhile to investigate possible relations between genes deleted in WS and genes outside the deleted region that have been previously implicated in anxiety disorders in the general population. Research in this area likely will yield valuable new findings for determining the etiology of anxiety disorders in the general population.
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